Navigation Links
Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
Date:11/21/2007

SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the 19th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2007, at 9:00 a.m. EST (6:00 a.m. PST). The conference is being held at the Pierre Hotel in New York.

Steve Worland, Ph.D., President and Chief Executive Officer of Anadys Pharmaceuticals, Inc., will present an overview of Anadys and its two development-stage product candidates, ANA598 and ANA773.

The presentation will be simultaneously webcast and can be accessed on the Investor Relations page of the Company's website at http://www.anadyspharma.com. Listeners are encouraged to visit the website approximately five minutes prior to the corporate presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the live webcast concludes and will be available through December 11, 2007.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. The Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C virus (HCV) infection and ANA773, an oral TLR7 agonist prodrug for cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel small molecule medic
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire/--BlueMarbleEnergyCorp.announcedtodaythatthe...)wererecentlyawarded$2millionbyWashingtonState,sCo.../publicpartnershiptoconstructthestate,sfirstspecia... "Thisinvestmentwillsignificantlyspeedthedevelopme...County,"saidBlueMarbleEnergyCEOKellyOgilvie."Weare...
(Date:11/24/2009).../PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc.(...duledtopresentatthePiperJaffray21stAnnualHealthCar...8:30a.m.PacificTime)attheNewYorkPalaceHotelinNewYo...eOfficer,isscheduledtoprovideanoverviewofthecompan...ams. ,, Aliveaudiowebcastofthepresentationwillb...
(Date:11/24/2009)...swire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasda...iperJaffrayHealthCareConference.Theconferencewillb..., CTIwillpresentonTuesday,December1at11:00a.m.Eas...,spresentationwillbeavailableat www.celltherapeuti...s. , ,PiperJaffrayHealthCareConference,NewYorkPal...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--PDLBioPharma,Inc.(PD...ishedNovember27,2009astheex-dividenddateforits$200...hesecuritizationtransactioncompletedonNovember2,20...kholdersofrecordontherecorddate,December1,2009.NAS...at$1.67pershareofcommonstockforpurposesoftheex-div...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...hances NeoStem,s Presence in Anti-Aging Arena , ,...US: NBS), which is pioneering the pre-disease coll...stem cells for future medical need, announced toda...exclusive worldwide rights to innovative stem cell...nd body procedures and skin rejuvenation. , , The...
...D, Pa., Feb. 23 Endo Pharmaceuticals (Nasdaq: E... the tender offer by its wholly owned subsidiary, ...res of common stock of Indevus Pharmaceuticals, In...; Trust Company, the depositary for the tender off...rk City time, on February 20, 2009, the initial ex...
..., Calif., Feb. 23 CUREXO Technology Corporation, ...age-directed robotic products for orthopaedic appl...C(R) Surgical System, announced today that they wi...ion of Orthopaedic Surgeons Annual Conference at t...hrough the 27th, Booth #3456. , , For the first t...
Other Biology Technology:NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies 2NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies 3Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period 2Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period 3CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas 2
(Date:11/24/2009)...able in Spanish . , The presence of increas...matory substances in the blood, hinders the loss a...rch project of the University of Navarra conducted...chool of Pharmacy. , The project, entitled "A nu...he control of body weight and inflammation," exami...
(Date:11/23/2009)...community-associated strain of the deadly superbug...st common antibioticsposes a far greater health th...nto hospitals, according to a study in the Decembe...e new threat is easily picked up in fitness center...sed the overall burden of MRSA within hospitals, t...
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 1Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 2Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 1TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 2TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 4Cohen Launches Second Statewide Tour 57485 1Cohen Launches Second Statewide Tour 57485 2
...stralian researchers have discovered a new gene th...ate cancer, as well as diabetes. , The gene, calle...ustralian Institute for Medical Research,s (WAIMR)...Peter Leedman, in collaboration with Professor Ber... Texas. , "When we baited our hook and went fishi...
...the transport of proteins within cells may underli...such as Huntington,s, ALS and Kennedy disease. Und...hese diseases may offer targets for future therapy...re Neuroscience, researchers from the University o...ow a chemical pathway that is obstructed in Kenned...
...f UniQuest,s 2006 Trailblazer innovation competiti... for motoneuronal diseases based on modifying boto...onal diseases cause a degeneration of the nerve pa...re severe and physically debilitating disorders wh...cles. Many of the diseases are incurable. , Dr Me...
Other Biology News:Gene discovery opens door to tackling disease 2Mechanism for neurodenegerative diseases linked to transport proteins 2
...orm 96 assays on one plate. The new ArraySlide 96 ...mm) individual printing surfaces for multiple simu...alysis studies. Unlike other systems, this device ... presence of contaminating adhesives. The chamber ...
...orm 96 assays on four slides. The new ArraySlide 2...mm x 7mm) individual printing surfaces for multipl...ing analysis studies. Unlike other systems, this d...ng the presence of contaminating adhesives. The ch...
...integrins in vascular proliferation, adhesion, and...rin family of cell adhesion receptors consists of ...osed of an a and b subunit that associate in a non...ersity of the integrin family are based upon the p...
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Biology Products: